Search research articles
Contact Us
Filters
Showing results (111-120 of 182) with videos related to
Page
of 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2017
Development and Validation of the PREMM<sub>5</sub> Model for Comprehensive Risk Assessment of Lynch Syndrome
Fay Kastrinos, Hajime Uno, Chinedu Ukaegbu, et al.
Pancreas
|
November 17, 2022
A Phase II Study of Ziv-Aflibercept in Patients With Advanced Extrapancreatic Neuroendocrine Tumors
Kimberly Perez, Matthew H Kulke, Nora K Horick, et al.
Endocrine-Related Cancer
|
June 22, 2022
SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma
Kimberly Perez, Heather Jacene, Jason L Hornick, et al.
The Oncologist
|
January 18, 2019
Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome
Lowell B Anthony, Matthew H Kulke, Martyn E Caplin, et al.
Cancer
|
July 14, 2011
Interactions between environmental factors and polymorphisms in angiogenesis pathway genes in esophageal adenocarcinoma risk: a case-only study
Rihong Zhai, Yang Zhao, Geoffrey Liu, et al.
The Oncologist
|
November 27, 2024
The impact of immune-related adverse events on survival outcomes in a racially diverse population, with a focus on non-Hispanic Black patients
Amr Radwan, Chinmay T Jani, Omar Al Omari, et al.
Neuroendocrinology
|
May 3, 2021
Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study
Dieter Hörsch, Lowell Anthony, David J Gross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2005
Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer
Shuji Ogino, Jeffrey A Meyerhardt, Mami Cantor, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 27, 2012
Endostatin lowers blood pressure via nitric oxide and prevents hypertension associated with VEGF inhibition
Sarah B Sunshine, Susan M Dallabrida, Ellen Durand, et al.
British Journal of Cancer
|
March 11, 2015
Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours
A J Zurita, M Khajavi, H-K Wu, et al.
Page
of 19
Search research articles
Search
Showing results (111-120 of 182) with videos related to
Sort By:
Page
of 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2017
Development and Validation of the PREMM<sub>5</sub> Model for Comprehensive Risk Assessment of Lynch Syndrome
Fay Kastrinos, Hajime Uno, Chinedu Ukaegbu, et al.
Pancreas
|
November 17, 2022
A Phase II Study of Ziv-Aflibercept in Patients With Advanced Extrapancreatic Neuroendocrine Tumors
Kimberly Perez, Matthew H Kulke, Nora K Horick, et al.
Endocrine-Related Cancer
|
June 22, 2022
SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma
Kimberly Perez, Heather Jacene, Jason L Hornick, et al.
The Oncologist
|
January 18, 2019
Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome
Lowell B Anthony, Matthew H Kulke, Martyn E Caplin, et al.
Cancer
|
July 14, 2011
Interactions between environmental factors and polymorphisms in angiogenesis pathway genes in esophageal adenocarcinoma risk: a case-only study
Rihong Zhai, Yang Zhao, Geoffrey Liu, et al.
The Oncologist
|
November 27, 2024
The impact of immune-related adverse events on survival outcomes in a racially diverse population, with a focus on non-Hispanic Black patients
Amr Radwan, Chinmay T Jani, Omar Al Omari, et al.
Neuroendocrinology
|
May 3, 2021
Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study
Dieter Hörsch, Lowell Anthony, David J Gross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2005
Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer
Shuji Ogino, Jeffrey A Meyerhardt, Mami Cantor, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 27, 2012
Endostatin lowers blood pressure via nitric oxide and prevents hypertension associated with VEGF inhibition
Sarah B Sunshine, Susan M Dallabrida, Ellen Durand, et al.
British Journal of Cancer
|
March 11, 2015
Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours
A J Zurita, M Khajavi, H-K Wu, et al.
Page
of 19